Phase I/II study of AT-101 in combination with topotecan in patients with relapsed or refractory small cell lung cancer after prior platinum containing first line chemotherapy

Heist, R. S., Molina, J. R., Urba, W. J., Mirshahidi, H., Grunberg, S., Maleski, J., … Lynch, T. J. (2008). Phase I/II study of AT-101 in combination with topotecan in patients with relapsed or refractory small cell lung cancer after prior platinum containing first line chemotherapy. Journal of Clinical Oncology, 26(15_suppl), 19004–19004. https://doi.org/10.1200/jco.2008.26.15_suppl.19004